Published in TB and Outbreaks Week, February 16th, 2010
"A recent breakthrough has been the introduction of orally administered miltefosine for the treatment of visceral, cutaneous, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.